Relapses of sarcoidosis: what are they and can we predict who will get them?
University of Cincinnati Medical Center, Cincinnati, OH.
Robert P
RP
Baughman
Marc A
MA
Judson
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D012507:Sarcoidosis / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab